Markus Tusche

1.4k citations

19 papers · 1.1k indexed · 1 hit paper · h-index 12

Impact in

Physiology top 2%
- Alzheimer's disease research and treatments
Biomaterials top 5%
- Supramolecular Self-Assembly in Materials

Papers in ⓘ

Physiology 15
- Alzheimer's disease research and treatments 15
Molecular Biology 8
- Protein Structure and Dynamics 4

Co-authors: Dieter Willbold (18 shared papers)Lothar Gremer (8 shared papers)Wolfgang Hoyer (4 shared papers)Elke Reinartz (4 shared papers)Henrike Heise (3 shared papers)Jörg Labahn (2 shared papers)Raimond B. G. Ravelli (2 shared papers)C. Schenk (2 shared papers)
Journals: ACS Chemical Neuroscience (3 papers)Scientific Reports (3 papers)European Journal of Pharmaceutical Sciences (2 papers)PLoS ONE (2 papers)Neuropeptides (1 paper)
Partner nations: Germany United States Australia

In The Last Decade

Markus Tusche

19 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Fibril structure of amyloid-β(1–42) by cryo–electron microscopy 2017 · 802 citations

Peers

Countries citing papers authored by Markus Tusche

Since Specialization

Citations

This map shows the geographic impact of Markus Tusche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Tusche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Tusche more than expected).

Fields of papers citing papers by Markus Tusche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Tusche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Tusche. The network helps show where Markus Tusche may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Tusche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Tusche Line = papers co-authored together Markus Tusche links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Fibril structure of amyloid-β(1–42) by cryo–electron microscopy Science ·Lothar Gremer, Daniel Schölzel, C. Schenk, Elke Reinartz, Jörg Labahn, Raimond B. G. Ravelli, Markus Tusche, Carmen López‐Iglesias, Wolfgang Hoyer, Henrike Heise, Dieter Willbold, Gunnar F. Schröder Hit paper breakdown →	2017	802
2	The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology Scientific Reports ·Thomas van Groen, Sarah Schemmert, Oleksandr Brener, Lothar Gremer, Tamar Ziehm, Markus Tusche, Luitgard Nagel‐Steger, Inga Kadish, Elena Schartmann, Anne Elfgen, Dagmar Jürgens, Antje Willuweit, Janine Kutzsche, Dieter Willbold	2017	47
3	Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy Journal of Biological Chemistry ·Anna König, Nadine S. Rösener, Lothar Gremer, Markus Tusche, Daniel Flender, Elke Reinartz, Wolfgang Hoyer, Philipp Neudecker, Dieter Willbold, Henrike Heise	2021	30
4	Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease Molecules ·Janine Kutzsche, Sarah Schemmert, Markus Tusche, Joerg Neddens, Roland Rabl, Dagmar Jürgens, Oleksandr Brener, Antje Willuweit, Birgit Hutter‐Paier, Dieter Willbold	2017	29
5	Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species ACS Chemical Neuroscience ·Tamar Ziehm, Oleksandr Brener, Thomas van Groen, Inga Kadish, Daniel Frenzel, Markus Tusche, Janine Kutzsche, Kerstin Reiß, Lothar Gremer, Luitgard Nagel‐Steger, Dieter Willbold	2016	26
6	Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers Scientific Reports ·Anne Elfgen, Michelle Hupert, Kevin Bochinsky, Markus Tusche, Estíbaliz González de San Román, Ian Gering, Silvia Sacchi, Loredano Pollegioni, Pitter F. Huesgen, Rudolf Hartmann, Beatrix Santiago‐Schübel, Janine Kutzsche, Dieter Willbold	2019	23
7	Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers ACS Chemical Neuroscience ·Antonia Klein, Tamar Ziehm, Thomas van Groen, Inga Kadish, Anne Elfgen, Markus Tusche, Maren Thomaier, Kerstin Reiß, Oleksandr Brener, Lothar Gremer, Janine Kutzsche, Dieter Willbold	2017	23
8	Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination PLoS ONE ·Antonia Klein, Tamar Ziehm, Markus Tusche, Johan Buitenhuis, Dirk Bartnik, Annett Boeddrich, Thomas Wiglenda, Erich E. Wanker, Susanne Aileen Funke, Oleksandr Brener, Lothar Gremer, Janine Kutzsche, Dieter Willbold	2016	19
9	Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity PLoS ONE ·Stephan Rudolph, Antonia Klein, Markus Tusche, Christine Schlosser, Anne Elfgen, Oleksandr Brener, Charlotte E. Teunissen, Lothar Gremer, Susanne Aileen Funke, Janine Kutzsche, Dieter Willbold	2016	13
10	Direct binding to GABARAP family members is essential for HIV-1 Nef plasma membrane localization Scientific Reports ·Alexandra Boeske, Melanie Schwarten, Peixiang Ma, Markus Tusche, Jessica Mötter, Christina Möller, Philipp Neudecker, Silke Hoffmann, Dieter Willbold	2017	12
11	Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold Pharmaceuticals ·Raphael J. Eberle, Ian Gering, Markus Tusche, Philipp Niklas Ostermann, Lisa Müller, Ortwin Adams, Heiner Schaal, Danilo S. Olivier, Marcos Serrou do Amaral, Raghuvir K. Arni, Dieter Willbold, Mônika A. Coronado	2022	12
12	Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all-d-enantiomeric peptides developed for the treatment of Alzheimer's disease European Journal of Pharmaceutical Sciences ·Elena Schartmann, Sarah Schemmert, Tamar Ziehm, Leonie H. E. Leithold, Nan Jiang, Markus Tusche, N. Jon Shah, Karl‐Josef Langen, Janine Kutzsche, Dieter Willbold, Antje Willuweit	2017	11
13	In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease Journal of Alzheimer s Disease ·Elena Schartmann, Sarah Schemmert, Nicole Niemietz, Dominik Honold, Tamar Ziehm, Markus Tusche, Anne Elfgen, Ian Gering, Oleksandr Brener, N. Jon Shah, Karl‐Josef Langen, Janine Kutzsche, Dieter Willbold, Antje Willuweit	2018	10
14	Aβ oligomer eliminating compounds interfere successfully with pEAβ(3–42) induced motor neurodegenerative phenotype in transgenic mice Neuropeptides ·Tina Dunkelmann, Kerstin Teichmann, Tamar Ziehm, Sarah Schemmert, Daniel Frenzel, Markus Tusche, Christina Dammers, Dagmar Jürgens, Karl‐Josef Langen, Hans‐Ulrich Demuth, N. Jon Shah, Janine Kutzsche, Antje Willuweit, Dieter Willbold	2017	8
15	Ligand-Induced Stabilization of the Native Human Superoxide Dismutase 1 ACS Chemical Neuroscience ·Karoline Santur, Elke Reinartz, Yi Lien, Markus Tusche, Tim Altendorf, Marc Sevenich, Gültekin Tamgüney, Jeannine Mohrlüder, Dieter Willbold	2021	8
16	Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies International Journal of Molecular Sciences ·Tim Altendorf, Ian Gering, Beatrix Santiago‐Schübel, Selma Aghabashlou Saisan, Gültekin Tamgüney, Markus Tusche, Dominik Honold, Sarah Schemmert, Wolfgang Hoyer, Jeannine Mohrlüder, Dieter Willbold	2023	6
17	Oral absorption enhancement of the amyloid-β oligomer eliminating compound RD2 by conjugation with folic acid European Journal of Pharmaceutical Sciences ·Anne Elfgen, Beatrix Santiago‐Schübel, Michelle Hupert, Sarah Schemmert, Elena Schartmann, Markus Tusche, Ian Gering, Christian Zafiu, Janine Kutzsche	2020	4
18	Backbone 13C and 15N Chemical Shift Assignments for fibrillar Amyloid Beta (1-42) Journal of Back and Musculoskeletal Rehabilitation ·Lothar Gremer, Daniel Schoelzel, C. Schenk, Elke Reinartz, Jörg Labahn, Raimond B. G. Ravelli, Markus Tusche, Carmen López‐Iglesias, Wolfgang Hoyer, Henrike Heise, Dieter Willbold, G.F. Schroeder	2017	3
19	Elevated Aβ aggregates in feces from Alzheimer’s disease patients: a proof-of-concept study Alzheimer s Research & Therapy ·Marlene Pils, Alexandra Dybala, Anja Schaffrath, Fabian Rehn, Janine Kutzsche, Lara Blömeke, Markus Tusche, Pelin Özdüzenciler, Tuyen Bujnicki, Victoria Kraemer‐Schulien, Hannes Gramespacher, Maximilian H.T. Schmieschek, Michael T. Barbe, Oezguer A. Onur, Gereon R. Fink, Gültekin Tamgüney, Oliver Bannach, Dieter Willbold	2024	1

About Markus Tusche

Markus Tusche is a scholar working on Physiology, Molecular Biology, Oncology, Biomaterials and Computational Theory and Mathematics, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (15 papers), Protein Structure and Dynamics (4 papers), Computational Drug Discovery Methods (3 papers), Supramolecular Self-Assembly in Materials (3 papers), Amino Acid Enzymes and Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Advanced NMR Techniques and Applications (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Physiology (788 citations), Biomaterials (196 citations), Computational Theory and Mathematics (193 citations), Structural Biology (15 citations) and Biological Psychiatry (24 citations). Markus Tusche has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Dieter Willbold, Lothar Gremer, Wolfgang Hoyer, Elke Reinartz, Henrike Heise, Jörg Labahn, Raimond B. G. Ravelli, C. Schenk, Gunnar F. Schröder and Carmen López‐Iglesias. Their work appears in journals such as ACS Chemical Neuroscience, Scientific Reports, European Journal of Pharmaceutical Sciences, PLoS ONE and Neuropeptides.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact